Chenxi Wang
Xiamen University
8 Papers
7 Citations
Chenxi Wang is an academic researcher from Xiamen University. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 2, co-authored 7 publications.
Chat about Author
Papers
Optimization of the Cuff Technique for Murine Heart Transplantation.
Yunhan Ma,Baiyi Xie,Helong Dai,Chenxi Wang,Shujiao Liu,Tian-Shu Lan,Shuangyue Xu,Guoliang Yan,Zhongquan Qi +8 more
TL;DR: This report on the improved cuff technique will offer practical guidance for murine heterotopic heart transplantation and will enhance the utility of this mouse model for basic research.
12
The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury.
Chenxi Wang,Junjun Guo,Anjie Di,Yu Zhu,Wei-Min Han,An-Ran Cheng,Cheng Li,Rui-Chan Si,Tian-Shu Lan,Ran Zhang,Hong-Li Liu,Guoliang Yan +11 more
TL;DR: In this article, the effect of phosphocreatine on myocardial ischemia/reperfusion (I/R) model was established by the ligation balloon method.
Skin transcriptomic analysis and immune-related gene expression of golden pompano (Trachinotus ovatus) after Amyloodinium ocellatum infection.
TL;DR: In this paper , an extensive analysis at the transcriptome level of T. ovatus skin was carried out at 24 h post-infection by Amyloodinium ocellatum .
7
Berberine Prolongs Mouse Heart Allograft Survival by Activating T Cell Apoptosis via the Mitochondrial Pathway.
Yunhan Ma,Guoliang Yan,Junjun Guo,Fujun Li,Haiping Zheng,Chenxi Wang,Yingyu Chen,Yuhan Ye,Helong Dai,Zhongquan Qi,Guohong Zhuang +10 more
TL;DR: Zhang et al. as discussed by the authors used a major histocompatibility complex complete mismatch mouse heterotopic cardiac transplantation model to examine whether berberine can prolong allograft survival by regulating the recruitment and function of T cells.
Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1/IRF3-regulated-IFN-γ production.
Yingyu Chen,Guoliang Yan,Yunhan Ma,Mengya Zhong,Yan Yang,Junjun Guo,Chenxi Wang,Wei-Min Han,Liyi Zhang,Shuangyue Xu,Jinjin Huang,Helong Dai,Zhongquan Qi,Zhongquan Qi +13 more
TL;DR: In this article, mesenchymal stem cells (MSC) and low-dose tacrolimus (FK506) were combined in heart transplant recipients, and in vitro and in vivo experiments were conducted to identify the mechanisms regarding MSC and FK506 combination (MF group) use in regulating IFN-γ signaling.
6